Dobutamine: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "==Sources==" to "==References==") |
Neil.m.young (talk | contribs) (Text replacement - "* " to "*") |
||
| Line 43: | Line 43: | ||
*Mechanism of Action: | *Mechanism of Action: | ||
===Primary Receptor=== | ===Primary Receptor=== | ||
* β1 | *β1 | ||
* β2 | *β2 | ||
===Relative Effects=== | ===Relative Effects=== | ||
*↑↑↑SV | *↑↑↑SV | ||
Revision as of 16:42, 4 July 2016
General
- Type: Vasopressors
- Dosage Forms:
- Common Trade Names:
Adult Dosing
Dosing
- 2-20mcg/kg/min
- 10mcg works for most
- May use in peripheral IV
Rate of Titration
- Q2-5 min
Pediatric Dosing
Special Populations
- Pregnancy Rating:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
- Tachyarrhythmias
- Myocardial ischemia
- Hypotension as β2 effect may result in vasodilation
- Caution if SBP <90
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action:
Primary Receptor
- β1
- β2
Relative Effects
- ↑↑↑SV
- ↑↑HR
- ↓SVR (transient, from β2 agonism)
Notes
Indications
- Cardiogenic shock
- Low-output heart failure
- Tricyclic overdose